TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6.027
AS - Asia 5.257
EU - Europa 3.555
SA - Sud America 1.020
AF - Africa 87
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.967
Nazione #
US - Stati Uniti d'America 5.878
SG - Singapore 1.842
HK - Hong Kong 1.254
CN - Cina 1.016
RU - Federazione Russa 901
BR - Brasile 827
IT - Italia 664
VN - Vietnam 559
IE - Irlanda 490
DE - Germania 472
SE - Svezia 395
GB - Regno Unito 140
ID - Indonesia 115
IN - India 97
AR - Argentina 90
KR - Corea 90
CA - Canada 85
UA - Ucraina 74
FI - Finlandia 73
NL - Olanda 61
FR - Francia 55
BD - Bangladesh 50
AT - Austria 43
JP - Giappone 39
MX - Messico 34
ES - Italia 33
TR - Turchia 33
EC - Ecuador 32
IQ - Iraq 31
ZA - Sudafrica 30
DK - Danimarca 28
BE - Belgio 23
PL - Polonia 21
PK - Pakistan 19
CZ - Repubblica Ceca 17
SA - Arabia Saudita 16
VE - Venezuela 16
CO - Colombia 15
MA - Marocco 15
AU - Australia 13
TN - Tunisia 12
CH - Svizzera 11
EG - Egitto 11
PE - Perù 11
TH - Thailandia 11
CL - Cile 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
PH - Filippine 9
IR - Iran 8
LT - Lituania 8
UY - Uruguay 8
UZ - Uzbekistan 8
HN - Honduras 7
IL - Israele 7
KE - Kenya 7
MY - Malesia 7
NP - Nepal 7
EE - Estonia 6
TW - Taiwan 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
GR - Grecia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
DZ - Algeria 4
HR - Croazia 4
NO - Norvegia 4
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
NZ - Nuova Zelanda 3
OM - Oman 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
ER - Eritrea 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 15.957
Città #
Hong Kong 1.246
Singapore 1.121
Ann Arbor 669
Ashburn 556
Dublin 476
Chandler 403
Fairfield 387
Frankfurt am Main 278
New York 265
Princeton 223
Beijing 204
Ho Chi Minh City 193
Santa Clara 186
Houston 182
Hefei 181
Wilmington 176
Woodbridge 175
Los Angeles 164
Seattle 159
Milan 128
Hanoi 125
Cambridge 119
Dallas 109
Lawrence 107
Chicago 104
Jakarta 100
Altamura 99
Seoul 79
Moscow 73
The Dalles 68
São Paulo 67
Shanghai 61
Nuremberg 53
Toronto 48
Buffalo 47
Munich 47
San Diego 44
Salt Lake City 40
Jacksonville 37
Rome 36
Rio de Janeiro 34
London 32
Tokyo 31
Andover 24
Belo Horizonte 24
Lappeenranta 24
Guangzhou 23
Stockholm 23
Turku 23
Brussels 22
Brooklyn 21
Chennai 21
Helsinki 21
Dearborn 20
Nanjing 20
Brasília 19
Curitiba 19
Tampa 19
Boardman 18
Elk Grove Village 18
Haiphong 17
Kent 16
Atlanta 15
Council Bluffs 15
Bergamo 14
Boston 14
Dhaka 14
Hangzhou 14
Vienna 14
Da Nang 13
Falls Church 13
Guayaquil 13
Quận Bình Thạnh 13
San Francisco 13
Changsha 12
Lomas de Zamora 12
Mexico City 12
Porto Alegre 12
Pune 12
Florence 11
Fuzhou 11
Ha Long 11
Hải Dương 11
Johannesburg 11
Thái Nguyên 11
Warsaw 11
Washington 11
Biên Hòa 10
Brno 10
Columbus 10
Lima 10
Phoenix 10
Poplar 10
Quito 10
Shenzhen 10
Baghdad 9
Brescia 9
Campinas 9
Chengdu 9
Lancaster 9
Totale 9.762
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 346
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial 320
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial 270
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 233
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 226
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 226
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 218
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 212
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 192
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 190
Continuous subcutaneous insulin infusion in Italy: Third national survey 188
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 185
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 184
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 184
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 176
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 164
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 161
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 156
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 150
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 148
Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes 148
Open questions on basal insulin therapy in T2D: a Delphi consensus 147
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 147
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 145
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 142
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 141
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 138
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 136
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 135
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 131
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 129
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 128
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 128
Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial 127
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 124
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 122
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 122
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 122
The Hyperfiltering Kidney in Diabetes 122
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 119
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 118
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 117
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 117
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 116
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 116
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 115
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 114
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 113
Does denosumab exert a protective effect against COVID-19? Results of a large cohort study 112
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 112
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study 112
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 111
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 111
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 110
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 109
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 109
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 108
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 107
Kidney function in acromegaly: evidence from a long-term observational study 107
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 106
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 105
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 104
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 104
Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy 103
Preventing microalbuminuria in type 2 diabetes 102
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 102
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 102
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 102
Lipids and renal disease 100
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 100
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 99
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 98
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 97
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 96
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 95
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 95
Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 93
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 93
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 93
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 92
Treatment of diabetes in patients with kidney disease 90
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 89
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 89
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 89
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 88
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 88
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 86
Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study 86
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 86
The effect of Mindfulness therapy in acromegaly, a pilot study 85
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 85
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 84
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 83
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 83
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 83
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 82
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 82
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 81
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective 80
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 80
Totale 12.696
Categoria #
all - tutte 78.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021825 0 0 0 0 0 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20254.762 249 483 171 193 449 222 198 136 745 717 462 737
2025/20264.830 1.113 886 623 999 1.110 99 0 0 0 0 0 0
Totale 16.610